Buprenorphine Prescribing through Telemedicine and Telephone Evaluation: Time for an Overdue Update in Policy

Williams, K. D., and R. I. Field. 2022. Buprenorphine Prescribing through Telemedicine and Telephone Evaluation: Time for an Overdue Update in Policy. 

"It should not be more difficult for health care providers to prescribe life-saving medications that treat opioid use disorder than to prescribe addictive opioid pills themselves. Yet, that is the reality clinicians face today."

NAM Perspectives. Commentary, National Academy of Medicine, Washington, DC. https://doi.org/10.31478/202201d.





Popular posts from this blog

Prenatal Action for Taking Healthy Steps (PATHS) Toolkit

Image
The   PATHS toolkit   offers evidence-based educational resources about the use of medication to treat opioid use disorder (OUD) during and after pregnancy. Culturally and linguistically appropriate versions are also available for  American Indians & Alaska Natives  and Spanish speakers (coming soon) . Resources include videos, discussion guides, fact sheets, flyers, posters, and social media messaging.   https://ctnlibrary.org/paths-oud-nida-ctn-di/  
Read more

The Concept of Treatment-Refractory Addiction: A Call to the Field

Not all patients respond to effective and approved treatment interventions, and there has been growing recognition in the medical field of these “resistant” or refractory illnesses (eg, treatment-resistant depression, resistant hypertension). In the field of substance use disorders, there has not been an explicit acknowledgement of treatment-refractory addiction (TRA) despite substantial evidence that many patients do not respond to standard-of-care treatment interventions. This article provides a justification for TRA as a critically important condition to recognize and define. TRA is not conceptualized as a diagnosis, but as a signal that a current treatment approach has not worked. The article addresses areas in need of research and consensus in order to ensure the approach to TRA is uniform, thoughtfully addressed, and data-driven. By explicitly acknowledging TRA, clinicians, researchers, and patients and their families can begin to explore the unique features of this population an...
Read more